This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial (ACE_CARD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05491681
Recruitment Status : Not yet recruiting
First Posted : August 8, 2022
Last Update Posted : October 10, 2023
Information provided by (Responsible Party):
BioCardia, Inc.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : August 2025
Estimated Study Completion Date : December 2025